Retina Foundation Presents New Data & Conclusions at ARVO 2018
Development of the first patient-reported outcome measure for quality of life and functional vision designed for children with a broad spectrum of eye conditions.
Discovery that children with strabismus (crossed eyes), anisomteropia (unequal focus between the eyes), or both have unsteady fixation when looking with both eyes.
Reported evidence that treatment for both eyes in children with lazy eyes is more effective than patching in rehabilitating the fellow eye as well as the eye with low vision.
Update on the new technologies capable of identifying and quantifying rod function in the retina for patients with inherited retinal disease.
Reported on our evaluation of the safety and efficacy of a new drug for patients with a juvenile macular degeneration known as Stargardt disease.
Related ArticlesThe Phyllis G. & William B. Snyder Legacy Society Retina Foundation of the Southwest/Rebion Selected As “Partner of the Year” The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease Retina Foundation Launches Cutting-Edge Artificial Intelligence Project Retina Foundation Helps Avery